Vergenix FG
-
Biologics
CollPlant Expands European Sales Network: The Company Has Signed a Distribution Agreement in Greece and Cyprus for Vergenix®FG
NESS ZIONA, Israel, Nov. 28, 2017 /PRNewswire/ — CollPlant (TASE: CLPT, OTC: CQPTY) – a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue…
Read More » -
Recon
CollPlant Announces Completion of Patient Recruitment for Clinical Trial of Vergenix™FG (Flowable Gel) for the Treatment of Chronic Wounds
CollPlant Ltd. (TASE:CLPT; OTC:CQPTY), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products, announce that…
Read More »